Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Vertex Pharmaceuticals Incorporated    VRTX   US92532F1003

Delayed Quote. Delayed Nasdaq - 05/22 11:51:28 am
125 USD   -0.04%
05/17 VERTEX PHARMACE : New England Journal of Medicine Publishes Data fro..
05/15 S&P 500 MOVERS : Gmcr, nflx
05/14 NASDAQ 100 MOVE : Vrtx, vip
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
05/18/2015 05/19/2015 05/20/2015 05/21/2015 05/22/2015 Date
127.31(c) 128.31(c) 126.75(c) 125.05(c) 125 Last
1 641 804 1 097 069 1 704 889 1 202 635 358 760 Volume
+0.87% +0.79% -1.22% -1.34% -0.04% Change
More quotes
Financials ($)
Sales 2015 1 022 M
EBIT 2015 -354 M
Net income 2015 -474 M
Finance 2015 550 M
Yield 2015 -
Sales 2016 2 869 M
EBIT 2016 1 228 M
Net income 2016 957 M
Finance 2016 1 255 M
Yield 2016 -
PER 2015 -
PER 2016 35,28
EV / Sales 2015 29,3x
EV / Sales 2016 10,2x
Capitalization 30 481 M
More Financials
Company
Vertex Pharmaceuticals, Inc. engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases in specialty markets.It focuses on development and commercializing therapies for the treatment of cystic fibrosis; infectious... 
Sector
Pharmaceuticals
Calendar
06/04Shareholder meeting
More about the company
Surperformance© ratings of Vertex Pharmaceuticals Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on VERTEX PHARMACEUTICALS INC
07:37a VERTEX PHARMACEUTICALS : Assigned Patent
05/20 VERTEX PHARMACEUTICALS : to Present at the UBS Healthcare Conference on May 19
05/20 VERTEX PHARMACEUTICALS : Food and Drug Administration Advisory Panel Voted 12 to..
05/17 VERTEX PHARMACEUTICALS : New England Journal of Medicine Publishes Data from Two..
05/15 S&P 500 MOVERS : Gmcr, nflx
05/15 VERTEX PHARMACEUTICALS : Reports Food and Drug Administration Advisory Panel Vot..
05/14 VERTEX PHARMACEUTICALS : New Chalcogens Study Results Reported from Vertex Pharm..
05/14 VERTEX PHARMACEUTICALS : Findings in the Area of Influenza Reported from Vertex ..
More news
Sector news : Biopharmaceuticals
11:31a JOHNSON & JOHNSON : STELARA® Receives CHMP Positive Opinion For Treatment Of Ado..
11:23a TSX eases after recent rally as energy, financials drag
11:03a GLAXOSMITHKLINE : GSK submits Japan regulatory application for mepolizumab in se..
More sector news : Biopharmaceuticals
News from SeekingAlpha
05/15 SEEKING ALPHA'S BIOTECH WEEKLY : Orexigen's Wreck, Stagnant Gilead, And More
05/14 VERTEX : The FDA Advisory Committee Recommended Approval For Orkambi
05/13 PREMARKET GAINERS / LOSERS AS OF 9 : 10 am
05/12 Ad Comm votes 12 - 1 in favor of approval for Vertex's Orkambi
05/12 Positive Ad Comm vote for Vertex Pharma's Orkambi uncertain


Comments 
Advertisement
Chart VERTEX PHARMACEUTICALS INC
Duration : Period :
Vertex Pharmaceuticals Inc Technical Analysis Chart | VRTX | US92532F1003 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions